PLOD1
protein-codingprocollagen-lysine,2-oxoglutarate 5-dioxygenase 1, the group of Procollagen-lysine,2-oxoglutarate 5-dioxygenase family
Gene summary
Lysyl hydroxylase is a membrane-bound homodimeric protein localized to the cisternae of the endoplasmic reticulum. The enzyme (cofactors iron and ascorbate) catalyzes the hydroxylation of lysyl residues in collagen-like peptides. The resultant hydroxylysyl groups are attachment sites for carbohydrates in collagen and thus are critical for the stability of intermolecular crosslinks. Some patients with Ehlers-Danlos syndrome type VI have deficiencies in lysyl hydroxylase activity. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2015]
- LLH
- PLOD
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~41.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0016002
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0016002
Submitter: Genomics England PanelApp
Inheritance Pattern: AR
Disease ID:MONDO:0016002
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0016002
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0016002
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Cardiovascular; Dermatologic; Musculoskeletal; Ophthalmologic; Renal
Intervention: Cardiovascular; Ophthalmologic; Renal
Rationale: EDS VI may be clinically recognizable, but care may be considered related to issues such as potential severe vascular rupture (beneficial preventive measures include blood pressure management); Adequate hydration to prevent nephroliathisis may be beneficial; Though not frequent, individuals may demonstrate ophthalmologic sequelae (eg, glaucoma), and appropriate surveillance and preventive measures may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PLOD1 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_000302.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 7 | 339 | 7 | 354 | |
| missense | 1 | 6 | 489 | 40 | 2 | 538 |
| nonsense | 24 | 8 | 2 | 34 | ||
| start loss | 2 | 2 | ||||
| frameshift | 21 | 20 | 3 | 44 | ||
| splice donor/acceptor (+/-2bp) | 4 | 33 | 12 | 49 | ||
| Total | 52 | 68 | 513 | 379 | 9 | 1021 |
Highest pathogenic variant AF is 0.000118987125
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_000293.2 | 19 | MANE Select | |
| Ensembl | ENSP00000196061.4 | 19 | MANE Select | |
| RefSeq | NP_001303249.1 | 20 | Standard | |
| Ensembl | ENSP00000405372.1 | 8 | Standard |
Model Organisms & Knockout Phenotypes
Observed phenotypic effects in mouse and zebrafish models
| Gene / Model | Organism | Observed Phenotype |
|---|---|---|
| plod1a | Danio rerio | Structure: actinotrichium Quality: absent abnormal |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Lysine degradation - Homo sapiens (human)
- Collagen biosynthesis and modifying enzymes
- Collagen formation
- Extracellular matrix organization
Biological Process
- response to hypoxia
- cellular protein modification process
- protein O-linked glycosylation
- epidermis development
- peptidyl-lysine hydroxylation
Molecular Function
- iron ion binding
- procollagen-lysine 5-dioxygenase activity
- L-ascorbic acid binding
- procollagen glucosyltransferase activity
- protein homodimerization activity
Cellular Component
- endoplasmic reticulum membrane
- rough endoplasmic reticulum membrane
- extracellular exosome
- catalytic complex
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000196061
- Coding exons
- 19
- Length
- 41334
- Individuals with no LoFs
- 125690
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 58
- Defined
- 125748
- p
- 0.000231
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.394 | 423 | 446 | 0.948 | 0.0000306 | 4752 |
| Missense (PolyPhen) | 111 | 118.16 | 0.93939 | 1226 | ||
| Synonymous | -0.478 | 198 | 190 | 1.04 | 0.0000136 | 1421 |
| Loss of Function | 1.88 | 30 | 43.4 | 0.692 | 0.00000245 | 452 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00025 | 0.00025 | rare |
| Latino/Admixed American | 0.00012 | 0.00012 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00032 | 0.00032 | rare |
| South Asian | 0.00020 | 0.00020 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Part of a complex composed of PLOD1, P3H3 and P3H4 that catalyzes hydroxylation of lysine residues in collagen alpha chains and is required for normal assembly and cross-linkling of collagen fibrils (By similarity). Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens (PubMed:8621606, PubMed:10686424, PubMed:15854030). These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links (Probable). {ECO:0000250|UniProtKB:Q9R0E2, ECO:0000269|PubMed:10686424, ECO:0000269|PubMed:15854030, ECO:0000269|PubMed:8621606, ECO:0000305}.;
- Disease
- DISEASE: Ehlers-Danlos syndrome, kyphoscoliotic type, 1 (EDSKSCL1) [MIM:225400]: A form of Ehlers-Danlos syndrome, a group of connective tissue disorders characterized by skin hyperextensibility, articular hypermobility, and tissue fragility. EDSKSCL1 is an autosomal recessive form characterized by severe muscle hypotonia at birth, generalized joint laxity, scoliosis at birth, and scleral fragility and rupture of the ocular globe. {ECO:0000269|PubMed:10686424, ECO:0000269|PubMed:15666309, ECO:0000269|PubMed:15854030, ECO:0000269|PubMed:15979919, ECO:0000269|PubMed:8163671, ECO:0000269|PubMed:9617436}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Intolerance Scores
- LoFtool
- 0.378
- RVIS EVS
- -0.66
- RVIS percentile EVS
- 16.09
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- S
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.666
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | High |
| Cancer | Medium | Medium | Medium |